3.4. Analysis.

Comparison 3: Individuals with a confirmed diagnosis of SARS‐CoV‐2 infection and asymptomatic to mild disease, Outcome 4: Serious adverse events

Comparison 3: Individuals with a confirmed diagnosis of SARS‐CoV‐2 infection and asymptomatic to mild disease, Outcome 4: Serious adverse events